Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Interestingly, research has shown that even in animals lacking beta-3 adrenergic receptors, acute AOD-9604 administration still increased energy expenditure and fat oxidation, suggesting additional metabolic pathways may be involved beyond the primary beta-3 receptor mechanism
Shorter strands
Convenient Ampule Packaging The 5x 1g ampules format allows for organized handling and easier preparation of topical or cosmetic formulations
Tier 3 Manufacturer regulatory and trial communications Eli Lilly and Company
1 Given the limited published data for onabotulinumtoxinA in the management of TN, it is not offered as a first-line treatment
US$ 28.73
US$ 28.85
US$ 28.47
US$ 23.24
